Pharmacologic management of diabetic peripheral neuropathic pain

Bibliography

• Diabetes fact sheet. 2011. Available from: http://www.who.int/mediacenter/factsheets/fs312/en/index.html [Last accessed 12 January 2013]
   Google Scholar
• Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999;7:245-52
   Google Scholar
• Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008;31:1360-2366
   PubMed Web of Science ®Google Scholar
• Ziegler D, Rathmann W, Dickhaus T, et al. for the KORA Study Group. Prevalence of polyneuropathy in prediabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-9
   PubMed Web of Science ®Google Scholar
• Galer BS, Giana A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Prac 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Benbow SJ, Chan AW, Bowsher D, et al. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 1993;11:17-21
   Google Scholar
• Dyck PJ, Litchy WJ, Lehman KA, et al. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-21
   PubMed Web of Science ®Google Scholar
• Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008;120:1-34
   PubMed Web of Science ®Google Scholar
• Lee JH, Cox DJ, Mook DG, McCarty RC. Effects of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain 1990;40:105-7
   Google Scholar
• Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy. Am J Med 1984;77:79-82
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Malik R, Harris N, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy or rapid glycemic control (insulin neuritis). Diabetologia 1984;39:329-35
   Google Scholar
• Obrosova IG. Diabetes and the peripheral nerve. Biochim Biophys Acta 2009;1792:931-40
   PubMed Web of Science ®Google Scholar
• Schemmel KE, Padiyara RS, D'Souza JJ. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy; a review. J Diabetes Complications 2010;24:354-60
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982;5:386-90
   PubMed Web of Science ®Google Scholar
• Scadding JW. Development of ongoing activity, mechano-sensitivity and adrenaline sensitivity in severed peripheral nerve axons. Exp Neurol 1981;73:345-64
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011;27:629-38
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
   PubMed Web of Science ®Google Scholar
• Genuth S. Insights from the diabetes control and complications trial: epidemiology of diabetes interventions and complication study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract 2006;12:34-41
   PubMedGoogle Scholar
• UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Martin C.L, Albers J, Herman WH, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006;29:340-4
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;11:521-34
   PubMed Web of Science ®Google Scholar
• Bauman WA, Shaw S, Jayatilleke E, et al. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000;23:1227-31
   PubMed Web of Science ®Google Scholar
• Ting RZW, Szeto CC, Chan MHM, et al. Risk factors of vitamin B12 deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975-9
   PubMed Web of Science ®Google Scholar
• Andrès E, Noel E, Goichot B. Metformin-associated vitamin B12 deficiency. Arch Intern Med 2002;162:2251-2
   Google Scholar
• Gilligan MA. Metformin and vitamin B12 deficiency. Arch Intern Med 2002;162:484-5
   Google Scholar
• Shakher J, Stevens MJ. Update on the management of diabetic polyneuropathies. Diabetes Metab Syndr Obes 2011;4:289-305
   PubMedGoogle Scholar
• Stevens MJ, Li F, Drel VR, et al. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin-diabetic rats. J Pharm Exp Ther 2007;320:458-64
   PubMed Web of Science ®Google Scholar
• Ziegler D. Painful diabetic neuropathy. Diabetes Care 2009;32(Suppl 2):S414-19
   Google Scholar
• Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001;3:53-62
   PubMedGoogle Scholar
• Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004;110:697-706
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Malik RA, Arezzo J, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86
   PubMed Web of Science ®Google Scholar
• Rull JA, Quibrera R, Gonzalez-Millan H, Lozano CO. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969;5:215-18
   PubMed Web of Science ®Google Scholar
• McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047-52
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-9
   PubMed Web of Science ®Google Scholar
• Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004;63:865-73
   PubMed Web of Science ®Google Scholar
• Kochar DK, Jain N, Agarwal RP, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002;106:248-52
   PubMed Web of Science ®Google Scholar
• Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-6
   PubMed Web of Science ®Google Scholar
• Gorson KC, Schott C, Herman R, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999;66:251-2
   PubMed Web of Science ®Google Scholar
• Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009;361:1963-71
   Google Scholar
• Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Med Res Rev 1999;19:149-77
   PubMed Web of Science ®Google Scholar
• Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-56
   PubMed Web of Science ®Google Scholar
• Wernicke JF, Pritchett YL, D'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-20
   PubMed Web of Science ®Google Scholar
• Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758-65
   PubMed Web of Science ®Google Scholar
• Kajdasz DK, Iyengar S, Desaiah D, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007;29:2536-46
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18
   PubMed Web of Science ®Google Scholar
• Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Inter Med 1999;159:1931-7
   PubMed Web of Science ®Google Scholar
• Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008;31:1448-54
   PubMed Web of Science ®Google Scholar
• Pfizer Protocol No. 1008–040: A placebo-controlled trial of pregabalin and amitriptyline for treatment of painful diabetic peripheral neuropathy [article online]. 2007. Available from: http://www.clinicalstudyresults.org/drugdetails/?drug_name_id_203&sort_c.company_name&page_2&drug_id_1952 [Last Accessed 28 June 2007]
   Google Scholar
• Rosenstock J, Tuchman M, La Moreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628-38
   PubMed Web of Science ®Google Scholar
• Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-60
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254-63
   PubMed Web of Science ®Google Scholar
• Tolle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain 2008;12:203-13
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Arezzo J, Pauer L, et al. Pfizer Global R&D: pregabalin as treatment of painful diabetic peripheral neuropathy (DPN): nerve conduction and analgesic effect in a 13-week double-blind, placebo-controlled trial (Poster). Pain 2007;8(Suppl 1):S27
   Google Scholar
• Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004;63:2104-10
   PubMed Web of Science ®Google Scholar
• Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011;52:826-36
   PubMed Web of Science ®Google Scholar
• European Association for the Study of Diabetes (EASD) 48th Annual Meeting: abstract 48. Presented October 2, 2012.
   Google Scholar
• Tanenberg RJ, Irving GA, Risser RC, et al. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc 2011;86:615-26
   PubMed Web of Science ®Google Scholar
• Yarnitsky D, Granot M, Nahman-Averbuch H, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012;153:1193-8
   PubMed Web of Science ®Google Scholar
• Spallone V. Management of painful diabetic neuropathy: guideline guidance or jungle? Curr Diab Rep 2012;12:403-13
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113
   PubMed Web of Science ®Google Scholar
• Bellows BK, Dahal A, Jiao T, Biskupiak J. A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy. J Pain Palliat Care Pharmacother 2012;26:153-64
   PubMedGoogle Scholar
• Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly 2010;140:297-306
   PubMed Web of Science ®Google Scholar
• Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6
   PubMed Web of Science ®Google Scholar
• Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8
   PubMed Web of Science ®Google Scholar
• Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60:927-34
   PubMed Web of Science ®Google Scholar
• Mousa SA, Shaqura M, Khalefa BI, et al. Rab7 Silencing prevents µ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes 2013;62:1308-19
   Google Scholar
• Kozma CM, Benson C, Slaton TL, et al. Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy. Curr Med Res Opin 2012;28:1485-96
   PubMed Web of Science ®Google Scholar
• Yao P, Meng LX, Ma JM, et al. Sustained-release oxycodone tablets for moderate to severe painful diabetic peripheral neuropathy: a multicenter, open-labeled, postmarketing clinical observation. Pain Med 2012;13:107-14
   Google Scholar
• Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987;147:1442-4
   PubMed Web of Science ®Google Scholar
• Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992;15:159-65
   PubMed Web of Science ®Google Scholar
• The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991;151:2225-9
   Google Scholar
• Tandan R, Lewis GA, Krusinski PB, et al. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care 1992;15:8-14
   PubMed Web of Science ®Google Scholar
• Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% Capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract; 2012
   Google Scholar
• Martini C, Yassen A, Olofsen E, et al. Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza®) in diabetic neuropathic pain patients: detection of distinct response groups. J Pain Res 2012;5:51-9
   PubMedGoogle Scholar
• Campbell CM, Kipnes MS, Stouch BC, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012;153:1815-23
   PubMed Web of Science ®Google Scholar
• Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21
   PubMed Web of Science ®Google Scholar
• Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf
   Google Scholar
• Abbott CA, Malik RA, van Ross ER, et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011;34:2220
   PubMed Web of Science ®Google Scholar
• Sadosky A, Schaefer C, Mann R, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. Diabetes Metab Syndr 2013;6:79-92
   Google Scholar
• Tanenberg RJ, Clemow DB, Giaconia JM, Risser RC. Duloxetine compared with pregabalin for diabetic peripheral neuropathic pain management in patients with suboptimal pain response to gabapentin and treated without antidepressants: a post hoc analysis. Pain Pract 2013
   Google Scholar